FDA

Life sciences companies presenting at CED’s Life Science Conference recently also make PowerPoint presentations. After 11 minutes on stage, another presenter took their place. Immunotherapy company Heat Biologics broke from script and announced a $10 million series B round to complete one midstage study on its lead treatment candidate and two early stage trials for …